CLDX icon

Celldex Therapeutics
CLDX

Overview Fund Activity

160 hedge funds and large institutions have $2.3B invested in Celldex Therapeutics in 2021 Q3 according to their latest regulatory filings, with 44 funds opening new positions, 53 increasing their positions, 46 reducing their positions, and 14 closing their positions.

Holders
160
Holders Change
+29
Holders Change %
+22.14%
% of All Funds
2.81%
Holding in Top 10
11
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+120%
% of All Funds
0.19%
New
44
Increased
53
Reduced
46
Closed
14
Calls
$85.9M
Puts
$69.9M
Net Calls
+$16M
Net Calls Change
+$22.1M

Top Buyers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$303M
2
RCM
2
RA Capital Management
Massachusetts
$86.4M
3
Viking Global Investors
3
Viking Global Investors
Connecticut
$41.2M
4
CAC
4
Cowen and Company
New York
$35.1M
5
FAM
5
Fred Alger Management
New York
$28.4M

Top Sellers

1
EAM
1
Eventide Asset Management
Massachusetts
$60.9M
2
Adage Capital Partners
2
Adage Capital Partners
Massachusetts
$51.3M
3
ACP
3
Acuta Capital Partners
California
$18.2M
4
VC
4
Vivo Capital
California
$26.2M
5
PA
5
Perceptive Advisors
New York
$21.3M
Name Market Value Shares Shares
Change 		Shares
Change %
Fidelity Investments
1
Fidelity Investments
Massachusetts
$303M 5,615,333 +5,249,038 +1,433%
RI
2
RTW Investments
New York
$211M 3,908,947 – –
BlackRock
3
BlackRock
New York
$169M 3,133,770 +433,120 +16%
RG
4
Redmile Group
California
$164M 3,043,298 +31,217 +1%
Vanguard Group
5
Vanguard Group
Pennsylvania
$123M 2,276,199 +305,793 +16%
Wellington Management Group
6
Wellington Management Group
Massachusetts
$118M 2,180,352 +217,353 +11%
State Street
7
State Street
Massachusetts
$100M 1,857,118 -237,100 -11%
RCM
8
RA Capital Management
Massachusetts
$86.4M 1,600,000 +1,600,000 New
EAM
9
Eventide Asset Management
Massachusetts
$60.9M 1,128,000 -980,908 -47%
VA
10
VR Adviser
New York
$59.3M 1,098,174 -142,436 -11%
OM
11
Opaleye Management
Massachusetts
$53M 985,000 – –
Adage Capital Partners
12
Adage Capital Partners
Massachusetts
$51.3M 950,000 -868,478 -48%
T. Rowe Price Associates
13
T. Rowe Price Associates
Maryland
$47.4M 878,409 +489,361 +126%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$42.8M 792,507 +119,559 +18%
Citadel Advisors
15
Citadel Advisors
Florida
$42.3M 783,061 +411,890 +111%
Viking Global Investors
16
Viking Global Investors
Connecticut
$41.2M 762,296 +762,296 New
OCA
17
Octagon Capital Advisors
New York
$41.1M 761,398 +200,000 +36%
CAC
18
Cowen and Company
New York
$35.1M 649,278 +620,883 +2,187%
DCM
19
Driehaus Capital Management
Illinois
$29.8M 551,065 -34,246 -6%
Invesco
20
Invesco
Georgia
$28.8M 533,985 +103,578 +24%
FAM
21
Fred Alger Management
New York
$28.4M 525,867 +525,867 New
VC
22
Vivo Capital
California
$26.2M 484,453 -484,453 -50%
Northern Trust
23
Northern Trust
Illinois
$24.8M 459,113 +46,850 +11%
O
24
OrbiMed
New York
$22.4M 414,300 +414,300 New
PA
25
Perceptive Advisors
New York
$21.3M 393,613 -349,086 -47%
1
2 3 4 5